Strengths
Intas Pharmaceuticals boasts a highly qualified R&D team, which is crucial for innovation in the competitive pharmaceutical landscape.
The company has a diverse product portfolio that includes generics, oncology, and parenteral medications, catering to a wide range of healthcare needs.
Intas invests 6-7% of its turnover in R&D annually, demonstrating a strong commitment to developing new and effective pharmaceutical solutions.
The company has established a significant international market presence, with 70% of its revenues generated from abroad, particularly in the EU and US.
Intas is recognized as a 'Great Place to Work', indicating high employee satisfaction and engagement, which can enhance productivity and innovation.
The company has received global regulatory authority accreditations, ensuring that its products meet high-quality standards and can be marketed in various regions.
Intas is a pioneer in biosimilars and advanced therapies, positioning itself as a leader in emerging pharmaceutical technologies.
The strong growth rate of approximately 22% CAGR reflects Intas's effective business strategies and market demand for its products.